Therapeutic targeting of the oxidative stress generated by pathological molecular pathways in the neurodegenerative diseases, ALS and Huntington's
- 6 December 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 987, 177187
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation (SERB/CRG/2021/006856)
- Department of Science and Technology, Ministry of Science and Technology, India
- Ministry of Education
- Department of Biotechnology, Ministry of Science and Technology, India
This publication has 166 references indexed in Scilit:
- First‐in‐Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15‐Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral SclerosisClinical Pharmacology in Drug Development, 2022
- Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term OutcomeStem Cells Translational Medicine, 2019
- Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugsMedicinal Research Reviews, 2018
- Regulation of neuronal development and function by ROSFEBS Letters, 2018
- Use ofade1andade2mutations for development of a versatile red/white colour assay of amyloid-induced oxidative stress insaccharomyces cerevisiaeYeast, 2016
- Ascorbic acid-dependent GLUT3 inhibition is a critical step for switching neuronal metabolismJournal of Cellular Physiology, 2011
- Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria?Journal of Molecular Medicine, 2001
- Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouseAnnals of Neurology, 2000
- Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal gangliaAnnals of Neurology, 1997
- Oxidative damage to protein in sporadic motor neuron disease spinal cordAnnals of Neurology, 1995